2019
DOI: 10.1016/j.cbi.2019.108777
|View full text |Cite
|
Sign up to set email alerts
|

Nicorandil combats doxorubicin–induced nephrotoxicity via amendment of TLR4/P38 MAPK/NFκ-B signaling pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

6
21
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 47 publications
(27 citation statements)
references
References 44 publications
6
21
0
Order By: Relevance
“…The current study investigated the protective effect of crocin treatment on doxorubicin-induced nephrotoxicity. Doxorubicin administration caused significant deterioration of kidney function and marked histopathological changes, as reported previously [ 24 , 31 ], that were attenuated by coadministration of crocin.…”
Section: Discussionsupporting
confidence: 82%
“…The current study investigated the protective effect of crocin treatment on doxorubicin-induced nephrotoxicity. Doxorubicin administration caused significant deterioration of kidney function and marked histopathological changes, as reported previously [ 24 , 31 ], that were attenuated by coadministration of crocin.…”
Section: Discussionsupporting
confidence: 82%
“…Furthermore, apoptotic proteins such as Bax and caspase-3 undergo downregulation, while antiapoptotic factor Bcl-2 demonstrates an increase in expression to ameliorate DOX side effects [98]. Taking everything into together, studies demonstrate that inflammation, oxidative stress and apoptosis are induced following DOX exposure in normal cells and protective agents possess regulatory effect on aforementioned mechanisms in reducing adverse effects of DOX [99][100][101][102]. Figure 1 demonstrates the chemical structure of curcumin and doxorubicin.…”
Section: Doxorubicin: Cancer Resistance and Side Effectsmentioning
confidence: 99%
“…Research teams continue to investigate the nephrotoxic mechanisms of different widely used chemotherapy drugs, with hopes that in the future a panel of specific renal biomarkers can be used as the gold standard for early renal injury detection. Previous studies investigated the effect of the most frequent chemotherapy agents used in clinical practice on tubular renal cells and the effect on renal biomarkers [139,140,141,142,143,144,145,146,147] (Table 1).…”
Section: Future Directions/perspective Regarding Kim-1 In Drug-indmentioning
confidence: 99%